日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

新辅助化疗联合安罗替尼治疗可切除的头颈部鳞状细胞癌:一项 II 期试点试验

He, Qianting; Huang, Shuojin; Tang, Dongxiao; Cao, Congyuan; Zhou, Wanhang; Ling, Rongsong; Chen, Jie; Yun, Bokai; Zheng, Xin; Li, Yanchen; Wang, Anxun; Chen, Demeng

Author Correction: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils

作者更正:头颈癌中抗LAG-3联合抗PD-1疗法的耐药性是由Sox9+肿瘤细胞与Fpr1+中性粒细胞的相互作用介导的。

Wang, Xiaochen; Cheng, Maosheng; Chen, Shuang; Zhang, Caihua; Ling, Rongsong; Qiu, Shuqing; Chen, Ke; Zhou, Bin; Li, Qiuli; Lei, Wenbin; Chen, Demeng

Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils.

头颈癌对 LAG-3 抗 PD-1 疗法的耐药性是由 Sox9+ 肿瘤细胞与 Fpr1+ 中性粒细胞相互作用介导的

Wang Xiaochen, Cheng Maosheng, Chen Shuang, Zhang Caihua, Ling Rongsong, Qiu Shuqing, Chen Ke, Zhou Bin, Li Qiuli, Lei Wenbin, Chen Demeng

PCIF1 drives oesophageal squamous cell carcinoma progression via m6Am-mediated suppression of MTF2 translation.

PCIF1 通过 m6Am 介导的 MTF2 翻译抑制来驱动食管鳞状细胞癌的进展

Li Kang, Yi Yuxuan, Ling Rongsong, Zhang Caihua, Zhang Zhihui, Wang Yue, Wang Ganping, Chen Jie, Cheng Maosheng, Chen Shuang

Study on RNAi-based herbicide for Mikania micrantha

对基于RNAi的除草剂防治小花魔芋的研究

Mai, Jiantao; Liao, Lingling; Ling, Rongsong; Guo, Xiaolong; Lin, Jingying; Mo, Beixin; Chen, Weizhao; Yu, Yu

Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options

2019冠状病毒病的特征及相关治疗方案

Huang, Boxuan; Ling, Rongsong; Cheng, Yifan; Wen, Jieqi; Dai, Yarong; Huang, Wenjie; Zhang, Siyan; Lu, Xifeng; Luo, Yifeng; Jiang, Yi-Zhou

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2

利用计算机模拟设计靶向SARS-CoV-2刺突蛋白的抗病毒肽

Ling, Rongsong; Dai, Yarong; Huang, Boxuan; Huang, Wenjie; Yu, Jianfeng; Lu, Xifeng; Jiang, Yizhou